| Line Item | 2022-08-31 | Y/Y |
|---|---|---|
| R&D Expense | $809K | +6336.4% |
| SG&A Expense | $23K | +378.4% |
| Operating Income | -$1.6M | -154.8% |
| Interest Expense | $6K | +341.5% |
| Income Tax | $0 | — |
| Net Income | $2.0M | +607.1% |
| EPS (Basic) | $0.01 | — |
| EPS (Diluted) | $0.01 | — |
| Line Item | 2022-08-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $615K | +73.6% |
| Accounts Receivable | $5K | +7.1% |
| Current Assets | $3.2M | +671.7% |
| Total Assets | $3.2M | +674.2% |
| Total Liabilities | $358K | -15.0% |
| Stockholders' Equity | $2.9M | — |
| Line Item | 2022-08-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$970K | -137.6% |
| Investing Cash Flow | $1.1M | +258.0% |
| Financing Cash Flow | $131K | -67.9% |